These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30685537)

  • 21. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.
    Janssen KMJ; de Smit MJ; Withaar C; Brouwer E; van Winkelhoff AJ; Vissink A; Westra J
    J Clin Periodontol; 2017 Jun; 44(6):577-584. PubMed ID: 28370244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of ACPAs in at-risk individuals: Early targeting of the bone and joints.
    Schett G
    Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):53-58. PubMed ID: 29221598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
    RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Catrina A; Krishnamurthy A; Rethi B
    RMD Open; 2021 Mar; 7(1):. PubMed ID: 33771834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New autoantibodies associated with rheumatoid arthritis recognize posttranslationally modified self-proteins.
    Cantagrel A; Degboé Y
    Joint Bone Spine; 2016 Jan; 83(1):11-7. PubMed ID: 26639222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients.
    Germar K; Fehres CM; Scherer HU; van Uden N; Pollastro S; Yeremenko N; Hansson M; Kerkman PF; van der Voort EIH; Reed E; Maassen H; Kwakkenbos MJ; Bakker AQ; Klareskog L; Malmström V; de Vries N; Toes REM; Lundberg K; Spits H; Baeten DL
    Arthritis Rheumatol; 2019 Mar; 71(3):340-350. PubMed ID: 30277007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
    de Brito Rocha S; Baldo DC; Andrade LEC
    Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
    Konig MF; Giles JT; Nigrovic PA; Andrade F
    Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The B cell response to citrullinated antigens in the development of rheumatoid arthritis.
    Scherer HU; Huizinga TWJ; Krönke G; Schett G; Toes REM
    Nat Rev Rheumatol; 2018 Mar; 14(3):157-169. PubMed ID: 29416134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
    van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
    Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
    van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
    Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
    Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
    Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Trier NH; Holm BE; Heiden J; Slot O; Locht H; Jensen B; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
    J Immunol Methods; 2018 Mar; 454():6-14. PubMed ID: 29128424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis.
    Steen J; Forsström B; Sahlström P; Odowd V; Israelsson L; Krishnamurthy A; Badreh S; Mathsson Alm L; Compson J; Ramsköld D; Ndlovu W; Rapecki S; Hansson M; Titcombe PJ; Bang H; Mueller DL; Catrina AI; Grönwall C; Skriner K; Nilsson P; Lightwood D; Klareskog L; Malmström V
    Arthritis Rheumatol; 2019 Feb; 71(2):196-209. PubMed ID: 30152202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
    Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
    Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.
    Kono M; Yasuda S; Kono M; Atsumi T
    Scand J Rheumatol; 2018 May; 47(3):248-250. PubMed ID: 28480784
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
    Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
    Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of anti-citrullinated protein antibody in pathogenesis of RA.
    Ma H; Liang X; Li SS; Li W; Li TF
    Clin Exp Med; 2024 Jul; 24(1):153. PubMed ID: 38972923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis.
    Gudowska M; Gindzienska-Sieskiewicz E; Gruszewska E; Cylwik B; Sierakowski S; Szmitkowski M; Chrostek L
    Rev Bras Reumatol Engl Ed; 2017; 57(3):185-189. PubMed ID: 28535888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.